Crescentic Fibrillary Glomerulonephritis in the Setting of Immune Checkpoint Inhibitor Therapy: A Report of Two Cases

INTRODUCTION: Immune checkpoint inhibitor (ICPI) therapy is used to treat various malignancies; however, it can be associated with off-target effects including kidney injury. Acute tubulointerstitial nephritis is the most commonly described renal pathology associated with ICPIs, although less freque...

Descripción completa

Detalles Bibliográficos
Autores principales: DiFranza, Lanny T., Chafouleas, Eleas, Katipally, Swapna, Stokes, M.Barry, Kudose, Satoru, Sekulic, Miroslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126733/
https://www.ncbi.nlm.nih.gov/pubmed/37113492
http://dx.doi.org/10.1159/000528881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126733/
https://www.ncbi.nlm.nih.gov/pubmed/37113492
http://dx.doi.org/10.1159/000528881

Ejemplares similares